vs
JOINT Corp（JYNT）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
JOINT Corp的季度营收约是Protalix BioTherapeutics, Inc.的1.7倍（$15.2M vs $9.1M），JOINT Corp净利率更高（6.5% vs -60.3%，领先66.9%），JOINT Corp同比增速更快（3.1% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $334.7K），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -28.6%）
JOINT Corp是美国领先的脊椎按摩护理诊所运营方与特许经营商，主打高性价比的脊椎护理服务，推出会员制护理方案，面向寻求非侵入式肌肉骨骼疼痛管理及日常健康调理的消费者。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
JYNT vs PLX — 直观对比
营收规模更大
JYNT
是对方的1.7倍
$9.1M
营收增速更快
JYNT
高出53.0%
-49.9%
净利率更高
JYNT
高出66.9%
-60.3%
自由现金流更多
PLX
多$1.3M
$334.7K
两年增速更快
PLX
近两年复合增速
-28.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.2M | $9.1M |
| 净利润 | $991.1K | $-5.5M |
| 毛利率 | 81.4% | 49.4% |
| 营业利润率 | 4.9% | -51.1% |
| 净利率 | 6.5% | -60.3% |
| 营收同比 | 3.1% | -49.9% |
| 净利润同比 | 5510.5% | -184.8% |
| 每股收益（稀释后） | $0.06 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JYNTPLX
| Q4 25 | $15.2M | $9.1M | ||
| Q3 25 | $13.4M | $17.9M | ||
| Q2 25 | $13.3M | $15.7M | ||
| Q1 25 | $13.1M | $10.1M | ||
| Q4 24 | $14.7M | $18.2M | ||
| Q3 24 | $30.2M | $18.0M | ||
| Q2 24 | $30.3M | $13.5M | ||
| Q1 24 | $29.7M | — |
净利润JYNTPLX
| Q4 25 | $991.1K | $-5.5M | ||
| Q3 25 | $855.0K | $2.4M | ||
| Q2 25 | $93.4K | $164.0K | ||
| Q1 25 | $967.8K | $-3.6M | ||
| Q4 24 | $17.7K | $6.5M | ||
| Q3 24 | $-3.2M | $3.2M | ||
| Q2 24 | $-3.6M | $-2.2M | ||
| Q1 24 | $947.0K | — |
毛利率JYNTPLX
| Q4 25 | 81.4% | 49.4% | ||
| Q3 25 | 80.1% | 53.4% | ||
| Q2 25 | 79.1% | 62.5% | ||
| Q1 25 | 77.3% | 19.1% | ||
| Q4 24 | 78.4% | 78.7% | ||
| Q3 24 | 90.7% | 53.4% | ||
| Q2 24 | 90.7% | 29.8% | ||
| Q1 24 | 90.9% | — |
营业利润率JYNTPLX
| Q4 25 | 4.9% | -51.1% | ||
| Q3 25 | 1.2% | 11.9% | ||
| Q2 25 | -8.6% | 7.5% | ||
| Q1 25 | -5.2% | -41.0% | ||
| Q4 24 | 5.5% | 39.6% | ||
| Q3 24 | -1.6% | 22.2% | ||
| Q2 24 | -5.9% | -18.0% | ||
| Q1 24 | -1.4% | — |
净利率JYNTPLX
| Q4 25 | 6.5% | -60.3% | ||
| Q3 25 | 6.4% | 13.2% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 7.4% | -35.8% | ||
| Q4 24 | 0.1% | 35.6% | ||
| Q3 24 | -10.5% | 18.0% | ||
| Q2 24 | -11.9% | -16.4% | ||
| Q1 24 | 3.2% | — |
每股收益（稀释后）JYNTPLX
| Q4 25 | $0.06 | $-0.06 | ||
| Q3 25 | $0.06 | $0.03 | ||
| Q2 25 | $0.01 | $0.00 | ||
| Q1 25 | $0.06 | $-0.05 | ||
| Q4 24 | $0.01 | $0.10 | ||
| Q3 24 | $-0.21 | $0.03 | ||
| Q2 24 | $-0.24 | $-0.03 | ||
| Q1 24 | $0.06 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.6M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.1M | $48.2M |
| 总资产 | $61.0M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资JYNTPLX
| Q4 25 | $23.6M | $14.7M | ||
| Q3 25 | $29.7M | $13.6M | ||
| Q2 25 | $29.8M | $17.9M | ||
| Q1 25 | $21.9M | $19.5M | ||
| Q4 24 | $25.1M | $19.8M | ||
| Q3 24 | $20.7M | $27.4M | ||
| Q2 24 | $17.5M | $23.4M | ||
| Q1 24 | $18.7M | — |
股东权益JYNTPLX
| Q4 25 | $15.1M | $48.2M | ||
| Q3 25 | $22.7M | $52.9M | ||
| Q2 25 | $23.2M | $49.9M | ||
| Q1 25 | $22.8M | $45.2M | ||
| Q4 24 | $20.7M | $43.2M | ||
| Q3 24 | $20.5M | $32.4M | ||
| Q2 24 | $23.2M | $28.6M | ||
| Q1 24 | $26.2M | — |
总资产JYNTPLX
| Q4 25 | $61.0M | $82.3M | ||
| Q3 25 | $69.4M | $82.3M | ||
| Q2 25 | $73.2M | $78.5M | ||
| Q1 25 | $80.1M | $73.9M | ||
| Q4 24 | $83.2M | $73.4M | ||
| Q3 24 | $79.6M | $61.6M | ||
| Q2 24 | $82.4M | $91.5M | ||
| Q1 24 | $85.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.8M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $334.7K | $1.6M |
| 自由现金流率自由现金流/营收 | 2.2% | 17.8% |
| 资本支出强度资本支出/营收 | 9.9% | 4.4% |
| 现金转化率经营现金流/净利润 | 1.86× | — |
| 过去12个月自由现金流最近4个季度 | $-1.9M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流JYNTPLX
| Q4 25 | $1.8M | $2.0M | ||
| Q3 25 | $1.8M | $-3.7M | ||
| Q2 25 | $868.6K | $-5.2M | ||
| Q1 25 | $-3.7M | $-5.1M | ||
| Q4 24 | $9.4M | $4.0M | ||
| Q3 24 | $3.4M | $4.1M | ||
| Q2 24 | $-973.5K | $-3.6M | ||
| Q1 24 | $2.8M | — |
自由现金流JYNTPLX
| Q4 25 | $334.7K | $1.6M | ||
| Q3 25 | $1.5M | $-4.2M | ||
| Q2 25 | $363.6K | $-5.7M | ||
| Q1 25 | $-4.0M | $-5.4M | ||
| Q4 24 | $8.2M | $3.6M | ||
| Q3 24 | $3.2M | $4.0M | ||
| Q2 24 | $-1.2M | $-3.8M | ||
| Q1 24 | $2.4M | — |
自由现金流率JYNTPLX
| Q4 25 | 2.2% | 17.8% | ||
| Q3 25 | 10.9% | -23.7% | ||
| Q2 25 | 2.7% | -36.2% | ||
| Q1 25 | -30.8% | -53.0% | ||
| Q4 24 | 55.9% | 19.6% | ||
| Q3 24 | 10.6% | 22.4% | ||
| Q2 24 | -4.1% | -28.1% | ||
| Q1 24 | 8.1% | — |
资本支出强度JYNTPLX
| Q4 25 | 9.9% | 4.4% | ||
| Q3 25 | 2.4% | 2.8% | ||
| Q2 25 | 3.8% | 2.8% | ||
| Q1 25 | 2.5% | 3.0% | ||
| Q4 24 | 8.1% | 2.3% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | 0.9% | 1.3% | ||
| Q1 24 | 1.3% | — |
现金转化率JYNTPLX
| Q4 25 | 1.86× | — | ||
| Q3 25 | 2.07× | -1.58× | ||
| Q2 25 | 9.30× | -31.91× | ||
| Q1 25 | -3.82× | — | ||
| Q4 24 | 532.98× | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
